Gene transfer to the early-stage embryonic brain using the ultrasound image-guided gene delivery (UIGD) technique has proven to be valuable for investigating brain development. Thus far, this technology has been restricted to the study of embryonic neurogenesis. When this technique is designed to be employed for the study in adult animals, a long-term stable gene expression will be required. We attempted to develop a retroviral vector suitable for expressing exogenous genes in the brains of postnatal and adult mice in the context of the UIGD technique. Retroviral vectors containing four different long terminal repeats (LTRs) (each from Moloney murine leukemia virus (MoMLV), murine stem cell virus (MSCV), myeloproliferative sarcoma virus (MPSV) and spleen focus-forming virus (SFFV)) were compared using the well-known CE vector having the EF1a internal promoter as a control. The MS vector containing MSCV LTR produced a higher viral titer and a higher level of gene expression than other vectors including CE. The MS vector drove the gene expression in cultured neural stem cells for 3 weeks. Furthermore, the MS vector could efficiently deliver the gene to the mouse central nervous system, as transgene expression was found in various regions of the brains and spinal cords as well as in all major neural cell types. The data from an in vivo luciferase imaging analysis showed that the gene expression from the MS vector was sustainable for almost 3 months. Our data suggested that the MS vector would be suitable to construct mice containing the transgene expressed in the brain or spinal cord in a quick and cost-effective manner.
INTRODUCTION
The brain of the embryo is a good target to deliver exogenous genes. Efficient gene transfer into the embryonic brain can be achieved by injecting vectors into the amniotic cavity at embryonic day 8.5 (E8.5) when the neural tube is open or into the telencephalic ventricle after E9.5 when the neural tube has closed. The ultrasound image-guided gene delivery (UIGD) technique was developed to transfer the gene into the early-stage embryos (E8.5B10.5) whose brains are too small to target without using the imaging system. 1, 2 With this technique, the effects of genes on brain development could be efficiently studied. [1] [2] [3] [4] Furthermore, it is possible to develop animal models that overexpress or downregulate specific genes in the brain.
Adenoviral and retroviral vectors have been widely used as gene delivery vehicles. Adenoviral vectors can be prepared to a very high titer and can transduce non-dividing cells. Because adenoviruses do not integrate into the host chromosome, a long-term, stable gene expression cannot be achieved. In contrast, retroviral vectors are available at a relatively lower titer, and only transduce proliferating cells. However, they integrate into the host chromosome, and thus transduced cells are expected to contain the transgene until cell death. When the transgene needs to be studied during the postnatal stage, retroviral vectors would be more suitable than adenoviral vectors.
Developing transgenic or knock-out mice not only takes time and effort but is also a costly process. The UIGD technique might provide a useful way of producing mice carrying the transgene in a quick and cost-effective manner, before making the decision to launch a timeconsuming germ-line manipulation procedure. For the UIGD technique to be used for such a purpose, it is vital to achieve a long-term, stable gene expression. Gaiano et al. 2 previously reported the development of several retroviral vectors for the UIGD technique and the comparison of their titers and pattern of gene expression. However, their study was conducted mainly in embryos, and the long-term gene expression in the adult brain was not systematically investigated. In this study, we compared various retroviral long terminal repeats (LTRs) for the level and duration of transgene expression in adult animals as well as in embryos. Among four LTRs compared in this study, the murine stem cell virus (MSCV) LTR showed not only the highest titer but also a high level of stable gene expression in embryonic neural stem cells and also in the brains of adult mice. Furthermore, the in vivo luciferase imaging analysis indicated that the transgene could be expressed even at 14 weeks after birth. Our data suggested that the UIGD technique could be used to create adult mice expressing the gene of interest in brains, and that the MSCV LTR would be suitable for driving gene expression.
RESULTS

Retroviral vectors used in the study
Five retroviral vectors were compared in this study. Four of them have the same backbone called MT, except for the 3¢ LTR region. 5 MT is a minimum size Moloney murine leukemia virus (MoMLV)-based vector containing no viral coding sequences. 6 The MoMLV 3¢LTR of MT was replaced with LTRs from MSCV, myeloproliferative sarcoma virus (MPSV) and spleen focus-forming virus (SFFV) to produce three different retroviral vectors called MS, MP and MF, respectively ( Figure 1 ). When retroviral vector DNAs were transfected to packaging cells in the form of plasmid, the U3 of MoMLV 5¢LTR drove the transcription of viral genomic RNA. When actual retroviruses are prepared and used to transduce the target cells, a different LTR controls the expression of the transgene. Retroviral vector CE was utilized as a control in all experiments, because it has been frequently used as a gene delivery vehicle in various experiments involving the UIGD technique. [2] [3] [4] In the plasmid form, the genome size transcript of the retroviral vector is made from the HCMV immediate-early promoter. In transduced cells, however, the transgene is expressed from the EF1a promoter and also possibly from the MoMLV LTR.
To prepare retroviral vectors, plasmid DNAs having the retroviral vector sequence were transfected to 293T with gag-pol and env expression vectors. 7 After 2 days, cell-free viral supernatants were taken to transduce the target cells. Viral supernatants were concentrated by ultracentrifugation when needed. The titers of respective retroviral vectors were measured by fluorescence-activated cell sorting (FACS) using NIH3T3 cells, as the retroviral vectors used in this study did not have any drug-resistant gene. Different dilutions of cell-free viral supernatants or ultracentrifuge-concentrated viruses were used to transduce NIH3T3 cells, and 2 days later, the percentage of enhanced green fluorescent protein (eGFP)-positive cells were measured by FACS. The titer was determined using the standard graph based on fluorescence-positive cell percentage and dilution ratios.
Comparison of viral titers
As the volume of viral vectors that can be injected into the ventricle of an early stage embryonic brain is limited to approximately 1 ml, the vector titer is an important factor determining the success of the experiments. Retroviral vectors expressing eGFP were prepared in 293T cells using the three-plasmid transfection method, 7 and the same volume of viral supernatants was taken to transduce NIH3T3 cells. After 2 days, FACS analysis was performed to determine the transduction efficiency. As shown in Figure 2 , MT and MS presented the highest percentage of eGFP-positive cells (38.47% and 42.90%, respectively). When measured by FACS using NIH3T3 cells, 8 the viral titers of MT and MS were approximately 2Â10 7 TU ml À1 , while those of CE, MP and MF were about 1Â10 7 TU ml À1 (Figure 2 ). These results indicated that MT and MS containing MoMLV and MSCV LTRs, respectively, produced higher viral titer in this production system.
Comparison of gene expression level
To compare the level of gene expression, plasmid DNAs having the retroviral vector sequence were transfected to 293T cells, viral titer was determined by FACS using NIH3T3 cells and the same titer was used to transduce NIH3T3 cells, followed by FACS analysis. The mean fluorescence intensity of MT and MS was 1.5-and 3-times higher than that of CE, respectively, while MP and MF showed 30% lower level of gene expression as compared with this control vector (Figure 3) .
When the retroviral vector is delivered to the embryonic brain using the UIGD technique, the target cells are generally neural stem cells, which reside in the ventricular zone. At E14.5, the ventricular and subventricular zones of the ganglionic eminences were dissected and dissociated into a single-cell suspension. These neural stem cells were grown in the presence of fibroblast growth factors and epidermal growth factors, and transduced with the same titer of retroviral vectors, followed by FACS analysis. MS showed the highest level of gene expression, which was about 1.5-fold higher than that of CE. MF containing SFFV LTR that had previously been reported to drive a high level of gene expression in hematopoietic cells produced the lowest level in mouse primary neural stem cells (Figure 3 ). 9, 10 In summary, the MSCV LTR appears to work efficiently in mouse primary neural stem cells as well as NIH3T3 cells. Figure 1 Schematic representation of retroviral vectors. The CE vector used as a control, contains the MoMLV LTR at the 3¢ side while at the 5¢ end, U3 was replaced with the HCMV IE promoter. 2 The Xenopus EF1a promoter was used as an internal promoter. MT vector is a minimum size MoMLV-based vector containing no viral coding sequences. 6 The MoMLV 3¢LTR of MT was replaced with LTRs from MSCV, MPSV and SFFV to produce MS, MP and MF, respectively. MoMLV, Moloney murine leukemia virus; MSCV, murine stem cell virus; MPSV, myeloproliferative sarcoma virus; SFFV, spleen focusforming virus; HCMV IE promoter, human cytomegalovirus immediate-early promoter; EF1a promoter, elongation factor 1a promoter. Figure 4 ). These data suggested that gene expression from MoMLV, MSCV and MPSV LTRs was more stably maintained in mouse primary neural stem cells than that from Xenopus EF1a promoter or SFFV LTR.
Comparison of CE and MS vectors in mouse brains
The above data indicated that MS produced the highest titer and a relatively higher level of gene expression in a stable manner in primary neural stem cells, and thus this vector was chosen for use in further experiments. CE and MS expressing eGFP and mcherry, respectively, were constructed, and the same titer of these two vectors was coinjected into E9.5 embryonic brains using the UIGD technique. When the brains of postnatal day 21 (P21) mice were analyzed, both eGFP + cells and mcherry + cells were found in various regions of the brains, but the number of mcherry + cells was about 1.8-fold higher than that of eGFP + cells (Figure 5a ). To exclude the possible effect of transgenes, CE-mcherry and MS-eGFP were also constructed and compared. When the same titer of these vectors was delivered into E9.5 embryonic brains, the number of eGFP + cells was about 1.2-fold higher than that of mcherry + cells in the brains of P21 mice (Figure 5b ). These data suggested that MS drove the expression of the transgene more stably than CE in the mouse brain.
To test whether retroviral vectors have any effect on cell viability, MS-eGFP was injected into the ventricle of E9.5 embryos, and apoptotic cell death was measured at E14.5 by the TUNEL assay. As shown in Figure 6 , the number of TUNEL-positive cells in vectorinjected brains was similar to that in naïve brains. Furthermore, no A retroviral vector for gene delivery to mouse brain J Jang et al gross abnormality was observed in vector-injected embryos, suggesting that retroviral vectors injected into the embryonic brains did not produce any significant toxicity on developing neural cells.
Gene expression pattern of MS vector in various developmental stages of mouse central nervous system
The gene expression pattern of MS was analyzed in various developmental stages of mouse central nervous systems. MS-eGFP was injected into the ventricle of E9.5 embryos, and then the brains and spinal cords were analyzed at E14.5, P0, P28 and P42. In the E14.5 embryonic brain, eGFP + cells showing the morphologies of radial glial progenitor cells and neurons were found in the ventricular zone and the cortical plate, respectively (Figure 7a ). At P0, P28 and P42, cells expressing eGFP were also found in various regions of the brains. Most of the eGFP + cells in P28 and P42 mice had the morphologies of mature cells (Figure 7a ). Furthermore, MS was also found to be efficiently delivered to the spinal cords and expressed eGFP at all developmental stages (Figure 7b ). To determine whether MS can express a transgene in mature neurons, astrocytes and oligodendrocytes, a double immunofluorescence technique was used to detect eGFP together with cell typespecific markers, using the brains of P28 mice (Figure 7c ). eGFP expression was found in NeuN + (neuron), GFAP + (astrocyte) and RIP + (oligodendrocyte) cells. These data indicated that MS could efficiently transduce the central nervous systems of the mice and drive gene expression at various developmental stages and in mature neural cells, including neurons, astrocytes and oligodendrocytes.
Comparison of viral envelopes in mouse primary neural stem cells The envelope protein is one of the key factors determining gene delivery efficiency. To establish which envelope can more efficiently target primary neural stem cells, we compared four different envelope proteins, ecotropic, amphotropic, VSV-G and rabies-G. CE vector containing the nuclear localization signal-fused GFP sequence was transfected to 293T cells with vectors expressing respective envelopes. Cell-free viral supernatants were then taken and viral titer was determined by a one-step quantitative RT-PCR reaction. The same titer of the retroviral vector pseudotyped with different envelopes was used to transduce NIH3T3 cells and mouse primary neural stem cells. In NIH3T3 cells, the retroviral vector pseudotyped with ecotropic envelope showed the highest transduction efficiency (81.59%), while the transduction efficiency of the ones pseudotyped with either VSV-G or rabies-G envelopes was lower (13.10% or 11.50%, respectively) ( Figure 8 ). In contrast, the retroviral vector pseudotyped with VSV-G envelope presented the highest transduction efficiency (92.01%) in mouse primary neural stem cells (Figure 8 ). The amphotropic envelope, which gave the second-highest transduction efficiency in NIH3T3 cells, hardly transduced neural stem cells (2.79%). These results indicated that VSV-G envelope was the most efficient envelope for transducing mouse neural stem cells.
In vivo detection of gene expression using a luciferase-imaging technique
Using an in vivo luciferase-imaging technique, the kinetics of gene expression level can be monitored without killing animals. Lipshutz et al. 15 reported that when AAV vector expressing luciferase was injected into the peritoneum of the late-stage mouse embryos (E15), its expression could be detected using an in vivo imaging technique. Unlike the peritoneum, however, the brain is surrounded by skulls which may weaken the signal to be detected. To determine whether the expression of the luciferase gene transferred into early-stage embryonic brain could be detected using this imaging technique, we injected the MS vector expressing luciferase and eGFP bicistronically into the ventricle of E9.5 or E10.5 embryos, and monitored gene expression.
When the pregnant mouse was analyzed at E17.5, the luciferase expression was detected in the gene-transferred embryos (Figure 9a) . To analyze the kinetics of gene expression from MS, the genetransferred mouse was monitored after birth. The luciferase signal was detected in the brain of the postnatal mouse (Figure 9b) . Unexpectedly, strong signals were also detected in the tails and legs of most animals, but the exact mechanism remains to be elucidated by which retroviral vectors injected into the telencephalic ventricle of the embryo were delivered to these tissues. The signal level in the brain was decreased between 5 and 9 weeks of age, but was still detectable at 14 weeks of age (Figure 9b ). The decrease in the level of luciferase signal might be due to the increased thickness of the skull and skin, which might have disturbed the detection of the signal from the brain. Whatever the case is, these data indicated that the expression of the gene transferred into the mouse brain could be monitored using an in vivo luciferase imaging technique, and that MS could drive transgene expression in the mouse brain for at least 3.5 months.
DISCUSSION
Gene transfer to the early-stage embryonic brain using the UIGD technique has proven to be valuable in studying the development of the brain. [1] [2] [3] [4] However, this technology has primarily been used for the study of embryonic neurogenesis, but not that of gliogenesis or adult neurogenesis. In order to exploit this technique in these areas, a high level of stable gene expression in the brains of postnatal mice is required. In this study, we attempted to develop a retroviral vector suitable for this purpose. Four retroviral vectors containing different LTRs were compared with the CE vector, which has frequently been used in the previous experiments involving the UIGD technique as a control. The MS vector containing MSCV LTR produced the highest viral titer and a relatively higher level of stable gene expression in neural stem cells and mouse brains. The MS vector expressed a transgene not only in various developmental stages of the mouse central nervous systems but also in mature neural cells, including neurons, astrocytes and oligodendrocytes. Furthermore, using an in vivo luciferase-imaging system, gene expression from the MS vector was detectable in the brain for at least 3.5 months after birth.
In mice, gain-or loss-of-function studies have been performed mostly using transgenic or knock-out mice, respectively. However, germ-line manipulation is a costly and time-consuming process, and sometimes requires the identification of regulatory elements for specific spatial and temporal patterns. In contrast, the UIGD technique not only provides a quick and cost-effective way of creating animal models that overexpress or downregulate the gene of interest in the brains, but also allows the study of the cell-autonomous effect of the gene. Therefore, this technique might provide an alternative way of exploring the function of the gene in the mouse brain.
It has been reported that retroviral vectors become transcriptionally silenced in primitive cells. [11] [12] [13] [14] The retroviral vector driving the stable gene expression in the mouse brain is required in the adult brain of the organism to be studied. In primary neural stem cells, the gene expression from the CE vector containing the cellular promoter was shut down more easily than those from MT, MS and MP vectors containing viral LTRs. Moreover, when the same titer of the CE and MS vectors was coinjected into the embryonic brain, the MS vector drove the expression of the transgenes more stably than the CE vector in the adult mouse brain. It has previously been thought that the main reason for the retroviral silencing was the de novo methylation of CpG sequence in viral promoters, 11, 12, 14 and thus the use of a cellular promoter as an internal promoter had been expected to confer resistance to silencing. However, this does not seem to be the case for the CE vector. The intact MoMLV LTRs at both 5¢ and 3¢ ends might have influenced gene expression driven from the EF1a internal promoter. It has also been suggested that retroviral silencing may act through methylation-independent mechanisms, and methylation is only a secondary step in this pathway. [16] [17] [18] [19] Consistent with this, retroviral silencing was reported in mouse embryonic stem cells that are de novo methyltransferase (dnmt3a and dnmt3b) null. 16, 20 Up until now, when a UIGD technique is used, the only way to confirm whether embryos or adult mice have received the transgene has been to analyze brains taken from killed animals. In order to construct adult mouse models using the UIGD technique, therefore, gene-transferred mice should be discriminated against other littermates without killing. For this purpose, the use of non-invasive analysis method to detect the gene expression from the brain is required. When the luciferase gene was delivered to the embryo, the luciferase signal from the brain was detectable in adult mice as well as in embryos, using an in vivo luciferase-imaging technique. Our data indicated that luciferase could be used to differentiate gene-containing animals from others in a non-invasive way.
In conclusion, the MS vector appears to be an ideal gene delivery vehicle when the UIGD technique is used to develop an adult animal model as well as to study the effect of the gene on brain development. Furthermore, an in vivo luciferase-imaging technique can provide a quick and easy way of detecting gene-transferred mice.
MATERIALS AND METHODS
Cell culture
293T (CRL-11268) and NIH3T3 (CRL-1658) were purchased from the American Type Culture Collection (Manassas, VA, USA). 293T cells were maintained in Dulbecco's modified Eagle's medium supplemented with 10% fetal bovine serum. NIH3T3 cells were cultured in Dulbecco's modified Eagle's medium supplemented with 10% bovine serum.
Isolation and in vitro culture of mouse neural stem cells
The ganglionic eminences in E14.5 embryonic brains were dissected and washed twice in PBS. Samples were triturated using a fire-polished Pasteur pipette and run through a 40-mm cell strainer (Falcon, Franklin Lakes, NJ, USA). Cells were cultured in Dulbecco's modified Eagle's medium/F12 (Gibco, Rockville, MD, USA) with B27 supplement (Gibco), N2 supplement (Gibco), Pen Strep Glutamine (Gibco), 2 mg ml À1 heparin (Sigma, St. Louis, MO, USA), 20 ng ml À1 hFGFbasic (Pepro Tech, Rocky Hill, NJ, USA) and 10 ng ml À1 EGF (Pepro Tech).
Construction of retroviral vectors
CE, MT, MS, MP and MF vectors were described previously. 2, 5 The eGFP sequence was amplified using primers eGFP5 (5¢-ACGCGTGGATCCATGGTG AGCAAGGGCGAG-3¢) and eGFP3 (5¢-CTCGAGAGATCTTTACTTGTAC AGCTCGTC-3¢) with pIRES2 (internal ribosomal entry site)-EGFP (Clontech, Palo Alto, CA, USA) as a template. The amplified eGFP sequence was initially cloned into pGem T easy (Promega, Madison, WI, USA), resulting in pGem T easy-eGFP. The BamHI-BglII fragment of eGFP was inserted into the BglII site of CE or the BamHI site of MT, MS, MP and MF, resulting in CE-, MT-, MS-, MP-and MF-eGFP. The mcherry sequence was amplified using primers mcherry5 (5¢-GCTAGCCGCCACCATGGTG-3¢) and mcherry3 (5¢-ATGCATCT ACTTGTACAGC-3¢) with pmCherry-N1 (Clontech) as a template. The amplified mcherry sequence was initially cloned into pGem T easy, resulting in pGem T easy-mcherry. The EcoRI fragment of mcherry (Klenow-blunted) was introduced into the BglII site (Klenow-blunted) of CE or the BamHI site (Klenow-blunted) of MS, resulting in CE-mcherry and MS-mcherry, respectively. To construct MS expressing enhanced firefly luciferase (effluc) and eGFP bicitronically, EMCV IRES was amplified from MIN 21 using primers IRES5 (5¢-GGATCCAATTCCGCCCCTCTCCCTC-3¢) and IRES3 (5¢-GATCTTGTGG CCATATTATCATCGTG-3¢). The amplified fragment was initially cloned into pGem T easy, resulting in pGem T easy-IRES. The BamHI-BglII fragment of eGFP was inserted into the BglII site of pGem T easy-IRES, generating pGem T easy-IRES-eGFP. The BamHI-BglII fragment of IRES-eGFP was introduced into the BamHI site of MS, resulting in MS-IRES-eGFP. 
Retroviral vector production and transduction
Retroviral vector plasmids were transfected into 293T cells with gag-pol (pCA-gag-pol) and env-expressing vectors (pCA-Eco, Ampho, VSV-G or Rabies-G), using Lipofectamine-PLUS (Invitrogen, Carlsbad, CA, USA), according to the manufacturer's instructions. 5, 21 Supernatants were collected 48 h after transfection, filtered through a 0.45-mm filter and frozen at À80 1C until used. Concentrated viral stocks were prepared by ultracentrifugation for 90 min in a SW32 rotor (Beckman-Coulter, Fullerton, CA, USA) at 25 000 r.p.m. at 4 1C. Pellets were resuspended in 50 ml of PBS at 4 1C for about 12 h, and aliquots of virus were stored at -80 1C.
For transduction, NIH3T3 cells were seeded at 1Â10 5 in six-well plates on the previous day. Viral supernatants were added in the presence of polybrene (final concentration 8 mg ml À1 ). After 2 days of transduction, flow cytometry was performed on FACS (BD, Los Angeles, CA, USA) with the aid of CellQuest software (BD). In the case of mouse primary neural stem cells, ultracentrifugeconcentrated viruses were added in the presence of polybrene (final concentration 8 mg ml À1 ) and incubated at 37 1C for 4 h. After incubation, the cells were washed and cultured in the neural stem cell medium as described above.
Titeration of retroviral vectors
NIH3T3 cells were seeded at 1Â10 5 in six-well plates on the previous day. Different dilutions of cell-free viral supernatants or ultracentrifuge-concentrated viruses were added in the presence of polybrene (final concentration 8 mg ml À1 ). After 2 days the percentage of eGFP-positive cells were measured by FACS. The titer was determined using the linear portion of the graph of eGFP + cell%. The titer of retroviral vectors pseudotyped with various envelopes were determined by a one-step quantitative RT-PCR reaction, using the forward primer MIN (5¢-TTCTGGTAGGAGACGAGAACCTAAA-3¢), the reverse primer MIN 3¢ (5¢-ACAGAGACAACACAGAACGATGCT-3¢) and the probe (VIC-5¢-CAG TTCCCGCCTCCGTCTGAATTTTT-3¢-TAMRA).
In vivo injection into the ventricle of the embryonic brain
All animal procedures were approved by the Institutional Animal Care and Use Committee of Seoul National University. Timed pregnant CD-1 mice (Orient-Bio, Gyunggi-do, Korea) were used for viral injections, and embryos were considered 0.5-days old when a vaginal plug was detected in the morning. Virus delivery was performed into the telencephalic ventricle at E9.5 or E10.5, using the ultrasound-guided imaging as described previously. 2 Briefly, pregnant mice were anesthetized with Zoletil 50 (Virbac, Carros, France) and rompun (Bayer Korea, Korea). The uterus was exteriorized, and the fetuses were scanned, using the ultrasound biomicroscopic imaging system (Vevo660; VisualSonics, Toronto, ON, Canada). Ultracentrifuge-concentrated viruses containing polybrene (final concentration 80 mg ml À1 ) were injected into the telencephalic ventricle of E9.5 or E10.5 embryos.
Imaging of luciferase activity in vivo
Mice were anesthetized with Zoletil 50 and rompun. An aqueous solution of D-luciferin substrate (150 mg kg À1 ) (MIP, Ann Arbor, MI, USA) was injected into the peritoneal cavity 10 min before imaging. Images were collected for 30 or 40 s using the IVIS 100 imaging system (Xenogen, Alameda, CA, USA).
Immunohistochemistry
The following antibodies were used for immunofluorescence: rabbit anti-GFP (1:500, Invitrogen), mouse anti-NeuN (1:100, Millipore, Bedford, MA, USA), mouse anti-GFAP (1:200, Millipore), mouse anti-RIP (1:10, Developmental Studies Hybridoma Bank, University of Iowa, Iowa City, IA, USA). The secondary antibodies used in this study were as follows: Alexa Fluor 488-donkey anti-rabbit IgG (1:500, Invitrogen), Alexa Fluor 555-donkey antimouse IgG (1:500, Invitrogen). Sections were washed in PBS, then blocked for 1 h with PBS containing 1% fetal bovine serum and 0.2% Triton X-100. Sections were incubated in primary antibodies diluted in block overnight at 4 1C, then washed three times in PBST (PBS/0.1% Tween-20) and incubated with secondary antibodies diluted in block for 1 h at room temperature.
